NQO1 and adrenomyeloneuropathy: As reported in Figure 1, the analysis of gene expression shows a significant decrease (70%) of NQO1 in the patient with AMN, while consistent increases of GR (2.9-fold) transcripts have been found by qRT-PCR (Figure 1A, Table 2).